AKAP79

AKAP79
Name	A-kinase anchor protein 79
Uniprot	Q02952
Organism	Human

AKAP79 AKAP79 is a scaffolding protein that coordinates signaling complexes by anchoring enzymes to specific subcellular sites. It organizes cAMP-dependent Protein kinase A complexes with Protein phosphatase 2B, Protein kinase C, and other effectors to shape responses in neurons, endocrine cells, and immune cells. AKAP79 integrates inputs from receptors such as β-adrenergic receptor, NMDA receptor, and M1 muscarinic receptor to control synaptic plasticity, ion channel modulation, and gene expression.

Introduction

AKAP79 was identified in studies tying the regulatory subunit of Protein kinase A to neuronal membranes alongside investigations of long-term potentiation, synaptic plasticity, and receptor trafficking. Early biochemical work linked AKAP79 to anchoring modules explored in research by groups studying cAMP signaling, calcineurin regulation, and scaffolding concepts developed in labs focusing on MAP kinase cascades, PI3K pathways, and receptor-effector coupling. AKAP79 became central in models comparing anchoring proteins such as those characterized in yeast and mammalian systems researched at institutions like Harvard University and Stanford University.

Structure and isoforms

AKAP79 contains modular domains including an amphipathic helix that binds the regulatory subunit of Protein kinase A and sequences that interact with Protein phosphatase 2B (calcineurin) and Protein kinase C. Alternative splicing produces isoforms studied in comparative projects involving mouse and rat models used by laboratories across National Institutes of Health and university centers. Structural motifs have been mapped using tools and collaborations involving facilities such as Brookhaven National Laboratory, European Molecular Biology Laboratory, and cryo-EM centers at Max Planck Society-affiliated institutes. Domains responsible for membrane association have been characterized in the context of lipid-binding modules examined alongside proteins like PSD-95, GKAP, and Homer.

Cellular localization and targeting

AKAP79 localizes to postsynaptic densities, dendritic spines, and plasma membrane subdomains implicated in receptor signaling studied in hippocampal and cortical preparations from model organisms used at University College London, Cold Spring Harbor Laboratory, and The Scripps Research Institute. Targeting is mediated by interactions with membrane lipids and adaptor proteins identified in screens from consortia including Wellcome Trust-funded projects and collaborative networks at Broad Institute and European Bioinformatics Institute. Localization dynamics have been imaged using methods developed at facilities such as Max Planck Institute for Biophysical Chemistry and applied in live-cell work at University of California, San Diego and Johns Hopkins University.

Interacting partners and signaling complexes

AKAP79 assembles multi-enzyme complexes containing Protein kinase A, Protein phosphatase 2B (calcineurin), and Protein kinase C that modulate targets including ion channels (e.g., AMPA receptor, KCNQ channels, L-type calcium channel) and transcription factors such as CREB. Proteomic and interactome studies conducted in collaboration with centers like European Molecular Biology Laboratory, EMBL-EBI, and ProteomeXchange reveal interactions with scaffolds and adaptors characterized in research from MIT, Yale University, and UCSF. AKAP79-mediated complexes coordinate signaling downstream of receptors including NMDA receptor, AMPA receptor, mGluR, β-adrenergic receptor, and dopamine receptor families, integrating with pathways studied in contexts of Parkinson's disease, Alzheimer's disease, and psychiatric disorders investigated at institutes like NIH and Wellcome Trust Sanger Institute.

Physiological roles

AKAP79 contributes to synaptic plasticity, regulating long-term potentiation and long-term depression in hippocampal circuits explored in studies led at Columbia University, Princeton University, and University of Oxford. It modulates neuronal excitability through control of channels such as KCNQ2/KCNQ3 and Kir family members characterized in electrophysiology work from laboratories at University of California, San Francisco and University of Cambridge. AKAP79 influences hormone secretion in endocrine models studied at Yale School of Medicine and immune signaling processes examined at Imperial College London and Weizmann Institute of Science. Behavioral outcomes tied to AKAP79 function have been assessed in mouse models from centers including Cold Spring Harbor Laboratory and Jackson Laboratory.

Pathology and clinical significance

Dysregulation of AKAP79-associated complexes has been implicated in neurological and psychiatric conditions investigated in consortia involving National Institute of Mental Health and clinical centers such as Mayo Clinic and Cleveland Clinic. Altered anchoring affects pathways relevant to Alzheimer's disease, Parkinson's disease, epilepsy, and mood disorders, with translational studies pursued at Massachusetts General Hospital and Vanderbilt University Medical Center. Pharmacological strategies targeting AKAP79 interactions are being explored in industry and academic collaborations with groups at Pfizer, GlaxoSmithKline, and translational units at University of Pennsylvania and Stanford Medicine to modulate Protein kinase A and calcineurin signaling in disease contexts. Genetic and proteomic screens from initiatives at Broad Institute and NIH continue to evaluate AKAP79 as a node linking receptor signaling to clinical phenotypes.

Category:Scaffold proteins